Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Atazanavir--booster of the future?
D000069446:Atazanavir Sulfate; D002784:Cholesterol / Q000097:blood; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D011725:Pyridines / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D014280:Triglycerides; D000069446:Atazanavir Sulfate; D002784:Cholesterol